Variability and Outcomes of Medical and Lifestyle Management of Peripheral Arterial Disease at the Time of Lower Extremity Bypass

Abstract

Background: First-line treatment of peripheral arterial disease (PAD) involves medical therapy and lifestyle modification. Specifically, the 2016 American Heart Association/American College of Cardiology guidelines for the management of PAD make Class I recommendations for antiplatelet therapy, statin therapy, antihypertensive therapy, and cilostazol